# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Flannery O'Connor (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML046-SYN-TD
- Date: 1950-04-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Augusta Pemberton-Diallo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for primary care visit for joint pain and swelling, fevers, fatigue, a facial rash, and protein in the urine in a writer of 25. **S**

## Objective

Hemoglobin: 11 g/dL (low); White cell count: 3.3 10*3/uL (low); Lymphocytes: 0.8 10*3/uL (low); Platelets: 138 10*3/uL (low); Creatinine: 0.8 mg/dL; eGFR: 101 mL/min/1.73 m²; Potassium: 4.2 mmol/L; Albumin: 3.3 g/dL (low); ALT: 19 U/L; ESR: 52 mm/h (high); CRP: 0.6 mg/dL (high); Urine protein-to-creatinine ratio: 1.6 g/g (high); Urine red cells: 18 /[HPF] (high); PHQ-9: 7; Joint pain (0 to 10): 6. All results are synthetic.

BP 138/86 mmHg; pulse 96 bpm; respirations 16/min; temperature 37.9 °C; oxygen saturation 98% on room air; weight 60 kg; BMI 21.3 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Pain and swelling of the small joints of both hands, the wrists, and the knees for three months, with an hour of morning stiffness, evening fevers to 38 °C, fatigue, and a red rash over the cheeks and nose after sun; told elsewhere it might be rheumatoid arthritis; cause to be established; Protein and blood in the urine: protein-to-creatinine ratio 1.6 g/g and 18 red cells per high-power field, with normal creatinine; cause to be established. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for joint pain, no more than 3000 mg a day **S**

## Plan

- Inflammatory arthritis with fever, rash, cytopenias, and an abnormal urine: blood count, chemistry, ESR and CRP, urine microscopy and protein-to-creatinine ratio today; ANA, anti-dsDNA, anti-Sm, complements, and antiphospholipid antibodies; no NSAIDs with protein in the urine. Guideline: 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 2019;71(9):1400-1412 (2019); 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Rheumatol 2025;77(9):1115-1135 (2024) **S**
- Rheumatology consultation within ten days, to confirm the diagnosis, stage organ involvement, and plan treatment with her. Guideline: EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29 (2023) **S**
- Disclosure: every result explained to her directly and in plain words, with a written copy; her health shared only with the people she names. Guideline: EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29 (2023) **S**
- Sun protection: broad-spectrum sunscreen SPF 50 or higher, a wide-brimmed hat, and shade in the middle of the day. Guideline: EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29 (2023) **S**
